TSE:EXE Extendicare (EXE) Stock Price, News & Analysis C$10.24 -0.07 (-0.68%) (As of 05:32 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlines About Extendicare Stock (TSE:EXE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Extendicare alerts:Sign Up Key Stats Today's RangeC$10.23▼C$10.4350-Day RangeC$9.06▼C$10.7252-Week RangeC$6.63▼C$10.89Volume159,990 shsAverage Volume135,564 shsMarket CapitalizationC$854.73 millionP/E Ratio15.06Dividend Yield4.69%Price TargetC$10.00Consensus RatingHold Company OverviewExtendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.Read More… Extendicare Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks18th Percentile Overall ScoreEXE MarketRank™: Extendicare scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingHold Consensus RatingExtendicare has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageExtendicare has only been the subject of 2 research reports in the past 90 days.Read more about Extendicare's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Extendicare is 15.06, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 112.36.Price to Earnings Ratio vs. SectorThe P/E ratio of Extendicare is 15.06, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 87.05.Price to Book Value per Share RatioExtendicare has a P/B Ratio of 8.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for EXE. Dividend2.5 / 5Dividend StrengthModerate Dividend LeadershipExtendicare is a leading dividend payer. It pays a dividend yield of 5.14%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthExtendicare does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Extendicare is 70.59%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Extendicare's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for EXE. News and Social Media1.8 / 5News SentimentN/A News SentimentExtendicare has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Extendicare this week, compared to 1 article on an average week.Search InterestOnly 3 people have searched for EXE on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows2 people have added Extendicare to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Extendicare insiders have not sold or bought any company stock.Percentage Held by Insiders13.92% of the stock of Extendicare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 19.16% of the stock of Extendicare is held by institutions.Read more about Extendicare's insider trading history. Receive EXE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter. Email Address EXE Stock News HeadlinesExtendicare's Payment Could Potentially Have Solid Earnings CoverageDecember 17, 2024 | finance.yahoo.com3 Dividend Stocks That Pay Monthly Passive IncomeDecember 13, 2024 | msn.comHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.December 23, 2024 | Insiders Exposed (Ad)Extendicare Inc: Extendicare Announces 2024 Third Quarter Results and Early Redemption of 2025 DebenturesNovember 13, 2024 | finanznachrichten.deWhere to Invest $5,000 in OctoberOctober 29, 2024 | msn.comInvest $7,000 in This Dividend Stock for Immense Passive IncomeOctober 19, 2024 | msn.com3 No-Brainer Healthcare Stocks to Buy With $500 Right NowOctober 19, 2024 | msn.comExtendicare Announces October 2024 Dividend of C$0.04 per ShareOctober 15, 2024 | markets.businessinsider.comSee More Headlines EXE Stock Analysis - Frequently Asked Questions How have EXE shares performed this year? Extendicare's stock was trading at C$7.28 on January 1st, 2024. Since then, EXE stock has increased by 40.7% and is now trading at C$10.24. View the best growth stocks for 2024 here. How do I buy shares of Extendicare? Shares of EXE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Extendicare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Extendicare investors own include Enbridge (ENB), Enterprise Products Partners (EPD), Algonquin Power & Utilities (AQN), Bank of Nova Scotia (BNS), NVIDIA (NVDA), Pembina Pipeline (PPL) and BCE (BCE). Company Calendar Ex-Dividend for 10/15 Dividend9/27/2024Dividend Payable10/15/2024Ex-Dividend for 11/15 Dividend10/31/2024Dividend Payable11/15/2024Today12/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolTSE:EXE CUSIPN/A CIKN/A Webwww.extendicare.com Phone905-470-4000FaxN/AEmployees23,000Year FoundedN/APrice Target and Rating Average Stock Price TargetC$10.00 High Stock Price TargetC$11.00 Low Stock Price TargetC$8.50 Potential Upside/Downside-2.4%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)C$0.68 Trailing P/E Ratio15.07 Forward P/E Ratio16.71 P/E GrowthN/ANet IncomeC$59.44 million Net Margins4.28% Pretax MarginN/A Return on Equity60.00% Return on Assets7.16% Debt Debt-to-Equity Ratio305.80 Current Ratio0.60 Quick Ratio0.98 Sales & Book Value Annual SalesC$1.39 billion Price / Sales0.62 Cash FlowC$3.20 per share Price / Cash Flow3.20 Book ValueC$1.28 per share Price / Book8.01Miscellaneous Outstanding Shares83,470,000Free FloatN/AMarket CapC$855.57 million OptionableNot Optionable Beta1.26 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (TSE:EXE) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Extendicare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Extendicare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.